Research & Collaboration

Driving discoveries through collaboration

Our registry facilitates partnerships between academic institutions, pharmaceutical companies, and healthcare providers to accelerate bronchiectasis research.

Partner with us

Research Objectives

Research objectives supported by our data

Our comprehensive dataset supports multiple research objectives, including:

Epidemiology

Characterising the burden, prevalence, and natural history of bronchiectasis across Australia.

Microbiology

Identifying pathogens associated with exacerbations and chronic infection.

Treatment Outcomes

Evaluating the real-world effectiveness of current therapies.

Biomarkers

Discovering biological markers that predict disease progression.

Research Lab

Microbiome Research

The Thornton Lab at the University of Calgary leads translational microbiome research focused on bronchiectasis and other suppurative lung diseases. The lab studies the lower respiratory microbiome and the role of polymicrobial infections during periods of clinical stability and pulmonary exacerbation, with the aim of understanding how bacterial communities shape inflammation, infection, and disease progression.

This work is helping identify microbial patterns that may support more targeted treatments and future prevention strategies for people living with bronchiectasis.

Visit the Thornton Lab Website